Wellster plans to use the capital to expand its offerings to include additional medical treatment options and reach new target groups. Acquisitions of existing companies in the market are also being considered. The startup was founded in 2018 by Manuel Nothelfer and Nico Hribernik and combines telemedicine, medication, and digital therapies into treatment solutions, each focusing on a specific health topic. In Germany, Wellster operates the 'Spring' brand with the portals gospring.de and myspring.com, in addition to portals for mental health and medical self-tests.
Wellster wants to “expand its offerings for additional target groups”
The funding round comes at a key moment in the company’s development, says Manuel Nothelfer, Co-founder of Wellster Healthtech Group:
“It confirms our ambition to establish leadership in the European market and to expand our offerings to other target groups in the future, thus closing existing gaps in supply.”
Nico Hribernik, Co-Founder of Wellster, says:
"Our multi-platform strategy allows us to tailor personalized treatments to specific target groups. This enables us to better address individual health concerns, ultimately leading to improved treatment outcomes and greater patient confidence."
Most recently, in April, the company was able to secure a “Investment in the mid-single-digit million range", as it was called at the time. The Munich-based company's previous investors include HV Capital and Sevenventures, the HGDF family holding, the Flixbus founders Mato Peric, Jean-Remy von Matt, and Reinold Geiger.
